-Adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides

Author： Yoshimoto T.   Naruse M.   Irie K.   Tanabe A.   Seki T.   Tanaka M.   Imaki T.   Naruse K.   Muraki T.   Matsuda Y.   Demura H.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.351, Iss.1, 1998-06, pp. : 61-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel antagonist implicates the CB 1 cannabinoid receptor in the hypotensive action of anandamide

By Varga K.   Lake K.   Martin B.R.   Kunos G.  

European Journal of Pharmacology, Vol. 278, Iss. 3, 1995-05 ,pp. : 279-283

Elsevier

Access to resources Recommend Favorite

In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known 1 -adrenoceptor antagonist

By Orallo F.   Garcia-Ferreiro T.   Enguix M.J.   Tristan H.   Masaguer C.   Ravina E.   Cadavid I.   Loza M.I.  

General Pharmacology, Vol. 40, Iss. 2, 2003-02 ,pp. : 97-108

Elsevier

Access to resources Recommend Favorite

Naltrindole, a selective -opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action

By Patterson A.B.   Gordon F.J.   Holtzman S.G.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 47-54

Elsevier

Access to resources Recommend Favorite

Natriuretic peptides as therapeutic targets

By Mukaddam-Daher Suhayla  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 239-252

Informa Healthcare

Access to resources Recommend Favorite

Natriuretic Peptides: Future Use?

By  

Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. : 6-8

Karger

Access to resources Recommend Favorite